Home Compare FME.DE vs TECN.SW
Stock Comparison · Broad operating lead

Fresenius Medical Care vs Tecan Group: Which Stock Looks Stronger in 2026?

Fresenius Medical Care holds the cleaner structural position, with the lead spread across growth and profitability. Tecan does not offset that deficit through any equally strong structural edge elsewhere. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

This is not just a one-metric split: both growth and profitability materially support the lead. The overall score gap is 35 points in favour of Fresenius Medical Care AG.

Trajectory Similarity
0.71
Similar
Peer-set rank: #52
within Fresenius Medical Care AG's functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

A solid similarity means the pair shares a clearly comparable long-term financial profile, even if individual dimensions still differ.

The match is driven mainly by investment intensity and revenue stability.

Similarity drivers
investment intensityrevenue stability
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
FME.DE
Fresenius Medical Care AG
63
Peer-Score
Signal qualityMedium
vs
TECN.SW
Tecan Group AG
28
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

More than one operating dimension supports the result here.

Dimension spread: FME.DE vs TECN.SW Profitability 39 0 Stability 56 19 Valuation 86 81 Growth 71 0 FME.DE TECN.SW
Gap Ranking
#1 Growth +71
#2 Profitability +39
#3 Stability +37
#4 Valuation +5
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for FME.DE and TECN.SW Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer FME.DETECN.SW Relative valuation Structural strength

Fresenius Medical Care AG looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses peer-relative PE percentile (idx_pct_pe) and Forward P/E where available.

Relative Position vs Comparable Companies
Growth
Fresenius Medical Care AG ranks near the top of the group on growth; Tecan Group AG sits in the weaker half.
Profitability
Both sit in the weaker half on profitability, with Fresenius Medical Care AG still coming out ahead.
Growth — Dominant Gap
FME.DE
71
TECN.SW
0
Gap+71in favour of FME.DE

The current lead is backed by a stronger multi-year growth trajectory.

What else supports the lead

Profitability gives the lead a second hard layer of support, with a 6.7-point operating margin advantage.

What this means for the comparison

The lead is built on both growth and profitability, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the FME.DE vs TECN.SW comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar growth-and-profitability comparisons

Explore how FME.DE and TECN.SW each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.